BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas

  April 4, 2011

   · 

  1 min read
• Genetown

  ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkin’s Lymphoma

  April 4, 2011

   · 

  1 min read
• Business

  PDI, Inc. Announces Contract Extension With Revenue Value of Approximately $23 Million

  April 4, 2011

   · 

  2 min read
• Drug Development

  Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, Cxl-1020, at the 60th Annual American College of Cardiology Scientific Session

  April 4, 2011

   · 

  6 min read
• BioCapital

  NACDS Urges Flexibility, Continued Dialogue on Prescription Container Labeling Recommendations in Comments to U.S. Pharmacopeia

  April 4, 2011

   · 

  1 min read
• Business

  AnaBios Corporation Closes Series A Financing

  April 4, 2011

   · 

  2 min read
• Deals

  Pfizer Inc. Selling CAPSUGEL to KKR for $2.38 Billion, Could Set Stage For Other Divestitures

  April 4, 2011

   · 

  6 min read
• Policy

  FDA Staff Views Optimer Pharmaceuticals, Inc. Antibiotic Favorably

  April 4, 2011

   · 

  5 min read
• Drug Development

  Cell Therapeutics, Inc. Says Experimental Lymphoma Drug Offers High Response Rate

  April 4, 2011

   · 

  8 min read
• Deals

  Actelion Ltd. Board Nominees Deny Sale is Main Aim

  April 4, 2011

   · 

  1 min read